Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K E Cole

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Life Sciences|January 1, 1997
IP6: a novel anti-cancer agentA M Shamsuddin, I Vucenik, K E Cole
Cancer Research|March 1, 1986
Comparative ultrastructural effects of aflatoxin B1 on mouse, rat, and human hepatocytes in primary cultureK E Cole, I C Hsu, B F Trump
Experimental and Molecular Pathology|May 20, 1999
Increased insulin-like growth factor-1 protein in human left ventricular hypertrophyL B Pauliks, K E Cole, W J Mergner
Child: Care, Health and Development|November 21, 1998
Six month follow-up: the crucial test of multidisciplinary developmental assessmentD E Glaun, K E Cole, D S Reddihough
Cancer Detection and Prevention|January 1, 1989
Replicative cultures of adult human and rhesus monkey liver epithelial cellsJ F Lechner, K E Cole, R R Reddel, et al.
Journal of Gastroenterology and Hepatology|November 1, 1992
16,16-dimethyl prostaglandin E2 modulates aflatoxin B1-induced injury of rat hepatocytes in primary culture: possible role of cAMPN V Bergasa, J Vergalla, K E Cole, et al.
The Journal of Trauma|November 1, 1994
National survey of state trauma registries--1992M J Shapiro, K E Cole, M Keegan, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|March 1, 1985
Isolation and culture of hepatocytes from human liver of immediate autopsyI C Hsu, M M Lipsky, K E Cole, et al.
Carcinogenesis|May 1, 1988
In vitro binding of aflatoxin B1 and 2-acetylaminofluorene to rat, mouse and human hepatocyte DNA: the relationship of DNA binding to carcinogenicityK E Cole, T W Jones, M M Lipsky, et al.
Anticancer Research|January 19, 1999
IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell lineI Vucenik, K Tantivejkul, Z S Zhang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Life Sciences|January 1, 1997
IP6: a novel anti-cancer agentA M Shamsuddin, I Vucenik, K E Cole
Cancer Research|March 1, 1986
Comparative ultrastructural effects of aflatoxin B1 on mouse, rat, and human hepatocytes in primary cultureK E Cole, I C Hsu, B F Trump
Experimental and Molecular Pathology|May 20, 1999
Increased insulin-like growth factor-1 protein in human left ventricular hypertrophyL B Pauliks, K E Cole, W J Mergner
Child: Care, Health and Development|November 21, 1998
Six month follow-up: the crucial test of multidisciplinary developmental assessmentD E Glaun, K E Cole, D S Reddihough
Cancer Detection and Prevention|January 1, 1989
Replicative cultures of adult human and rhesus monkey liver epithelial cellsJ F Lechner, K E Cole, R R Reddel, et al.
Journal of Gastroenterology and Hepatology|November 1, 1992
16,16-dimethyl prostaglandin E2 modulates aflatoxin B1-induced injury of rat hepatocytes in primary culture: possible role of cAMPN V Bergasa, J Vergalla, K E Cole, et al.
The Journal of Trauma|November 1, 1994
National survey of state trauma registries--1992M J Shapiro, K E Cole, M Keegan, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|March 1, 1985
Isolation and culture of hepatocytes from human liver of immediate autopsyI C Hsu, M M Lipsky, K E Cole, et al.
Carcinogenesis|May 1, 1988
In vitro binding of aflatoxin B1 and 2-acetylaminofluorene to rat, mouse and human hepatocyte DNA: the relationship of DNA binding to carcinogenicityK E Cole, T W Jones, M M Lipsky, et al.
Anticancer Research|January 19, 1999
IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell lineI Vucenik, K Tantivejkul, Z S Zhang, et al.
Pageof 2